Imunon Investor Relations Material
Latest events
Q4 2024
Imunon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Imunon Inc
Access all reports
Imunon Inc. is a clinical-stage biotechnology company focused on the development of innovative therapies for oncology and infectious diseases. The company utilizes its proprietary ThermoDox platform, which combines heat-activated liposomal drug delivery with targeted chemotherapy to enhance treatment effectiveness. Imunon also engages in the development of DNA-based vaccines and immunotherapies aimed at improving patient outcomes. The company is headquartered in Lawrenceville, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
IMNN
Country
🇺🇸 United States